Langel Ü - Search Results

1

Effective in vivo gene delivery with reduced toxicity, achieved by charge and fatty acid -modified cell penetrating peptide.

Kurrikoff K, Veiman KL, Künnapuu K, Peets EM, Lehto T, Pärnaste L, Arukuusk P, Langel Ü. Kurrikoff K, et al. Among authors: langel u. Sci Rep. 2017 Dec 6;7(1):17056. doi: 10.1038/s41598-017-17316-y. Sci Rep. 2017. PMID: 29213085 Free PMC article.

2

Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.

Suhorutsenko J, Oskolkov N, Arukuusk P, Kurrikoff K, Eriste E, Copolovici DM, Langel U. Suhorutsenko J, et al. Among authors: langel u. Bioconjug Chem. 2011 Nov 16;22(11):2255-62. doi: 10.1021/bc200293d. Epub 2011 Oct 10. Bioconjug Chem. 2011. PMID: 21978260

3

Cell-penetrating peptides for the delivery of nucleic acids.

Lehto T, Kurrikoff K, Langel Ü. Lehto T, et al. Among authors: langel u. Expert Opin Drug Deliv. 2012 Jul;9(7):823-36. doi: 10.1517/17425247.2012.689285. Epub 2012 May 17. Expert Opin Drug Deliv. 2012. PMID: 22594635 Review.

4

PepFect14 peptide vector for efficient gene delivery in cell cultures.

Veiman KL, Mäger I, Ezzat K, Margus H, Lehto T, Langel K, Kurrikoff K, Arukuusk P, Suhorutšenko J, Padari K, Pooga M, Lehto T, Langel Ü. Veiman KL, et al. Among authors: langel u, langel k. Mol Pharm. 2013 Jan 7;10(1):199-210. doi: 10.1021/mp3003557. Epub 2012 Dec 14. Mol Pharm. 2013. PMID: 23186360

5

PEG shielded MMP sensitive CPPs for efficient and tumor specific gene delivery in vivo.

Veiman KL, Künnapuu K, Lehto T, Kiisholts K, Pärn K, Langel Ü, Kurrikoff K. Veiman KL, et al. Among authors: langel u. J Control Release. 2015 Jul 10;209:238-47. doi: 10.1016/j.jconrel.2015.04.038. Epub 2015 Apr 30. J Control Release. 2015. PMID: 25935707 Free article.

6

PepFects and NickFects for the Intracellular Delivery of Nucleic Acids.

Arukuusk P, Pärnaste L, Hällbrink M, Langel Ü. Arukuusk P, et al. Among authors: langel u. Methods Mol Biol. 2015;1324:303-15. doi: 10.1007/978-1-4939-2806-4_19. Methods Mol Biol. 2015. PMID: 26202277

7

CPP-Based Delivery System for In Vivo Gene Delivery.

Kurrikoff K, Veiman KL, Langel Ü. Kurrikoff K, et al. Among authors: langel u. Methods Mol Biol. 2015;1324:339-47. doi: 10.1007/978-1-4939-2806-4_22. Methods Mol Biol. 2015. PMID: 26202280

8

Characteristics of Cell-Penetrating Peptide/Nucleic Acid Nanoparticles.

Margus H, Arukuusk P, Langel Ü, Pooga M. Margus H, et al. Among authors: langel u. Mol Pharm. 2016 Jan 4;13(1):172-9. doi: 10.1021/acs.molpharmaceut.5b00598. Epub 2015 Dec 18. Mol Pharm. 2016. PMID: 26561739

9

Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.

Kurrikoff K, Gestin M, Langel Ü. Kurrikoff K, et al. Among authors: langel u. Expert Opin Drug Deliv. 2016;13(3):373-87. doi: 10.1517/17425247.2016.1125879. Epub 2015 Dec 22. Expert Opin Drug Deliv. 2016. PMID: 26634750 Review.

10

Optimization of in vivo DNA delivery with NickFect peptide vectors.

Freimann K, Arukuusk P, Kurrikoff K, Vasconcelos LDF, Veiman KL, Uusna J, Margus H, Garcia-Sosa AT, Pooga M, Langel Ü. Freimann K, et al. Among authors: langel u. J Control Release. 2016 Nov 10;241:135-143. doi: 10.1016/j.jconrel.2016.09.022. Epub 2016 Sep 21. J Control Release. 2016. PMID: 27664329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

382 results

Search Page